Introduction
 Thyroid nodules are widely prevalent; prevalence rates vary depending on population studied  Prevalence rates: clinically palpable thyroid nodule in 3-7%; radiologically proven thyroid nodules as high as 30-70% and increases with age  Increasing frequency of nodules being identified and investigated further, due to increased imaging modalities (Brito et al, BMJ 2013)  The incidence rates of papillary thyroid cancer is also increasing though the outcomes and mortality rates have remained comparable to past decades  11% of patients with U2 lesion were found to be malignant in our study  Even ignoring the microPTC, 4% could be missed  However even FNA was negative in these patients  FNA can be inconclusive in determining a follicular lesion -in our study there were 7 cases and the US findings were a combination of U2 and U3
 Size of the nodule is no longer a discriminatory criteria to chose a patient for FNA or surgery  CT is not a good modality of investigation to confirm benign nature  Inter-rater variability can be quite high, with various specialists and sonographers now reporting US or performing US for various reasons  Limitations to our study  Retrospective analysis -there were some limitations to all the data available on all patients and a large number of patients had to be excluded  It is difficult to say if the nodule being investigated was where the cancer was found from the histology report
• Data on 591 cases who had been operated so far reviewed
• N=88 were included for the study -main limitation being availability of US for re-analysing the U grading
• 27/88 were malignant based on post-operative histology
• On US
• 45 were U2
• 43 were U3 or above
• Of the U2 nodules (n=45)
• 36 benign on post op histology • All of these had Thy1 or Thy2 on FNAC
• 4 follicular adenomas on post op histology
• 5 were malignant
• 3 micropapillary carcinomas
• 2 over malignancies
• FNA were Thy1 or Thy2 in all 5 of these nodules
